Historique
Article de Périodique
Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program (2001)
Auteur(s) :
DES JARLAIS, D. C. ;
FISHER, D. G. ;
NEWMAN, J. C. ;
TRUBATCH B. N. ;
YANCOVITZ M. ;
PAONE, D. ;
PERLMAN, D.
Année
2001
Page(s) :
1791-1792
Langue(s) :
Anglais
Refs biblio. :
4
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
REDUCTION DES RISQUES ET DES DOMMAGES
;
HEPATITE
;
ECHANGE DE SERINGUES
;
PROGRAMME
;
PREVENTION DE PROXIMITE
;
ETUDE LONGITUDINALE
;
ENQUETE
Thésaurus géographique
ETATS-UNIS
Résumé :
Injection drug users (IDUs) are at very high risk for infection with hepatitis B virus (HBV) through multiperson use of injection equipment and through unprotected sexual contact. Although a safe and efficacious vaccine exists for hepatitis B, there are multiple problems in vaccinating IDUs in the United States, including (1) discrimination against drug users by health care providers, (2) the need to reach IDUs before they are exposed to HBV, (3) paying for the vaccinations, and (4) difficulties in completing the 3-injection vaccination series. We compared 2 methods for delivering free hepatitis B vaccination to IDUs: (1) referral by research staff to local health care providers and (2) on-site vaccination at a syringe exchange program. (Extract of the publication)
Affiliation :
Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA